myasthenia gravis
Neurology · 2025–2025
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| efgartigimod alfa Treatment of adult patients with generalised myasthenia gravis who are anti-acetylcholine receptor (AChR) antibody positive and remain symptomatic despite… | Mar 2025 | Recommended with restriction | 28 individuals Myasthenia Alliance Australia |
| ravulizumab Treatment of newly diagnosed and treatment-refractory adult patients with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR)… | Mar 2025 | Recommended with restriction | 16 individuals Myasthenia Alliance Australia |
Who spoke
Myasthenia Alliance Australia
What the PBS pays
$106M in government benefit over 2024–25, across 1,691 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| ravulizumab | $105.7M |
Registered, not subsidised
Medicines on the ARTG for this condition with no PBAC record at all. Registration and subsidy are separate decisions: a medicine can be legally available in Australia and never have been put to the committee.
| Medicine | On the ARTG since | Registrations |
|---|---|---|
| normal immunoglobulinCSL NORMAL IMMUNOGLOBULIN VF (human) 320mg/2mL injection vial | 1998 | 60 |
| pyridostigmine bromideMESTINON TIMESPAN pyridostigmine bromide 180mg tablet bottle | 1991 | 3 |
The ARTG export holds current registrations only, so the year is the earliest entry still on the register rather than a first-registration date. The condition here comes from the registered label, which is usually broader than the population a sponsor asks to have subsidised.
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.